IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 247 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $22,915,979 | -26.5% | 5,036,479 | +13.8% | 0.04% | -22.0% |
Q2 2023 | $31,164,257 | +42.9% | 4,426,741 | +24.0% | 0.05% | +38.9% |
Q1 2023 | $21,804,794 | +24.7% | 3,568,706 | +30.4% | 0.04% | +16.1% |
Q4 2022 | $17,481,328 | -33.9% | 2,735,732 | -0.8% | 0.03% | -32.6% |
Q3 2022 | $26,427,000 | -13.9% | 2,758,573 | -0.7% | 0.05% | -11.5% |
Q2 2022 | $30,678,000 | -32.1% | 2,778,802 | +2.5% | 0.05% | -13.3% |
Q1 2022 | $45,155,000 | -12.0% | 2,712,014 | +0.9% | 0.06% | -1.6% |
Q4 2021 | $51,309,000 | -27.5% | 2,687,730 | -6.3% | 0.06% | -29.1% |
Q3 2021 | $70,732,000 | -8.6% | 2,868,295 | -3.6% | 0.09% | -6.5% |
Q2 2021 | $77,392,000 | -18.1% | 2,974,334 | -0.3% | 0.09% | -22.7% |
Q1 2021 | $94,445,000 | -29.9% | 2,983,114 | +2.7% | 0.12% | -27.4% |
Q4 2020 | $134,721,000 | +44.5% | 2,903,469 | +2.5% | 0.16% | +24.2% |
Q3 2020 | $93,237,000 | +13.6% | 2,832,238 | -5.3% | 0.13% | +0.8% |
Q2 2020 | $82,080,000 | +52.2% | 2,990,153 | +66.0% | 0.13% | +13.9% |
Q1 2020 | $53,919,000 | +18.4% | 1,801,210 | +9.5% | 0.12% | +43.8% |
Q4 2019 | $45,537,000 | +106.3% | 1,645,117 | +35.7% | 0.08% | +90.5% |
Q3 2019 | $22,068,000 | -13.1% | 1,212,548 | +17.1% | 0.04% | -10.6% |
Q2 2019 | $25,388,000 | – | 1,035,396 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |